Dr Ole Tietz is a Senior Research Fellow and Group Leader at the Dementia Research Centre, Macquarie Medical School. Ole studied Chemistry at Imperial College London, UK, and completed his PhD in Oncology at the University of Alberta, Canada. He held research fellowships at the University of Cambridge, where he developed imaging agents for early markers of neurodegeneration, and the University of Oxford, where he developed new therapeutics to treat cancer. Ole leads the Chemistry Group at the Dementia Research Centre and seeks to develop effective agents to diagnose and treat neurodegenerative diseases.

Ole is interested in developing novel drugs for the effective diagnosis and treatment of neurodegenerative diseases, including Dementia, Alzheimer's Disease, Motor Neuron Disease, Parkinsons Disease, and Chronic traumatic encephalopathy. This includes the rational design of small molecules against protein-protein interfaces, and the development of biologics, including peptides and antibodies, to target important biomolecular pathways that drive disease progression in neurodegenerative disease. Ole's research is building therapeutics for a world without dementia.